Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis

C S Dalbøge; X C Nielsen; K Dalhoff; J W Alffenaar; M Duno; Anders Buchard; D R A Uges; A. G.  Jensen; G Jürgens; T Pressler; H K Johansen; N Høiby

doi:10.1016/j.jcf.2013.08.008

Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis

C S Dalbøge, X C Nielsen, K Dalhoff, J W Alffenaar, M Duno, Anders Buchard, D R A Uges, A. G. Jensen, G Jürgens, T Pressler, H K Johansen, N Høiby

10 Citationer (Scopus)

Abstract

To investigate the correlation between CYP3A4/5 activity and clarithromycin metabolism, and between CYP3A activity and CYP3A genotype.

Originalsprog	Engelsk
Tidsskrift	Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Vol/bind	13
Udgave nummer	2
Sider (fra-til)	179-85
ISSN	1569-1993
DOI	https://doi.org/10.1016/j.jcf.2013.08.008
Status	Udgivet - 2014

Adgang til dokumentet

10.1016/j.jcf.2013.08.008

Citationsformater

Dalbøge, C. S., Nielsen, X. C., Dalhoff, K., Alffenaar, J. W., Duno, M., Buchard, A., Uges, D. R. A., Jensen, A. G., Jürgens, G., Pressler, T., Johansen, H. K., & Høiby, N. (2014). Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 13(2), 179-85. https://doi.org/10.1016/j.jcf.2013.08.008

Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. / Dalbøge, C S; Nielsen, X C; Dalhoff, K et al.
I: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, Bind 13, Nr. 2, 2014, s. 179-85.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Dalbøge, CS, Nielsen, XC, Dalhoff, K, Alffenaar, JW, Duno, M, Buchard, A, Uges, DRA, Jensen, AG, Jürgens, G, Pressler, T , Johansen, HK & Høiby, N 2014, 'Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis', Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, bind 13, nr. 2, s. 179-85. https://doi.org/10.1016/j.jcf.2013.08.008

@article{d991d446dfc04377bc56793eb6a1648e,

title = "Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis",

abstract = "To investigate the correlation between CYP3A4/5 activity and clarithromycin metabolism, and between CYP3A activity and CYP3A genotype.",

author = "Dalb{\o}ge, {C S} and Nielsen, {X C} and K Dalhoff and Alffenaar, {J W} and M Duno and Anders Buchard and Uges, {D R A} and Jensen, {A. G.} and G J{\"u}rgens and T Pressler and Johansen, {H K} and N H{\o}iby",

note = "{\textcopyright} 2013.",

year = "2014",

doi = "10.1016/j.jcf.2013.08.008",

language = "English",

volume = "13",

pages = "179--85",

journal = "Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society",

issn = "1569-1993",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis

AU - Dalbøge, C S

AU - Nielsen, X C

AU - Dalhoff, K

AU - Alffenaar, J W

AU - Duno, M

AU - Buchard, Anders

AU - Uges, D R A

AU - Jensen, A. G.

AU - Jürgens, G

AU - Pressler, T

AU - Johansen, H K

AU - Høiby, N

PY - 2014

Y1 - 2014

N2 - To investigate the correlation between CYP3A4/5 activity and clarithromycin metabolism, and between CYP3A activity and CYP3A genotype.

AB - To investigate the correlation between CYP3A4/5 activity and clarithromycin metabolism, and between CYP3A activity and CYP3A genotype.

U2 - 10.1016/j.jcf.2013.08.008

DO - 10.1016/j.jcf.2013.08.008

M3 - Journal article

C2 - 24035278

SN - 1569-1993

VL - 13

SP - 179

EP - 185

JO - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

JF - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

IS - 2

ER -

Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater